3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Wilms Tumor
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Spinal Cord Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Leukemia
1
Hepatic Veno-Occlusive Disease
1
Glioma
1
Endometrial Hyperplasia
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
37
Cytarabine
27
Methotrexate
22
Dexamethasone
20
Vincristine
19
fludarabine
15
Mercaptopurine
14
Etoposide
14
Radiotherapy
12
Daunorubicin
12
Asparaginase
12
Doxorubicin
11
Prednisolone
9
Idarubicin
9
Busulfan
8
pegaspargase
7
blinatumomab
7
Peripheral Blood Stem Cell Transplantation
6
Melphalan
6
Immunotherapy, Adoptive
6
Imatinib Mesylate
6
Dasatinib
6
fludarabine phosphate
5
Prednisone
5
Methylprednisolone
5
Filgrastim
5
Whole-Body Irradiation
4
Thioguanine
4
Rituximab
4
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Genetic Testing
×
Clear all
NCT04168788
2019-11-19
MVO
University Hospital, Angers
Phase NA
Unknown
150 enrolled